CASCADE PRODRUG

cascade-prodrug-logo

Cascade Prodrug they give service for prostate, cervical, pancreatic, non-small cell lung cancer, and head and neck cancers.

#SimilarOrganizations #People #Financial #Website #More

CASCADE PRODRUG

Social Links:

Industry:
Biotechnology Health Care Personal Health Pharmaceutical Service Industry Therapeutics

Founded:
2009-01-01

Address:
Eugene, Oregon, United States

Country:
United States

Website Url:
http://www.cascadeprodrug.com

Total Employee:
1+

Status:
Active

Contact:
(541)343-6025

Email Addresses:
[email protected]

Total Funding:
1.65 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

pharmakea-therapeutics-logo

PharmAkea Therapeutics

PharmAkea is a biopharmaceutical company developing small molecule drug candidates targeting proteins in fibroproliferative diseases.


Current Advisors List

eric-boothe_image

Eric Boothe Board Member @ Cascade Prodrug
Board_member

chris-schelling_image

Chris Schelling Board Member @ Cascade Prodrug
Board_member
2017-06-01

Current Employees Featured

august-j-sick_image

August J. Sick
August J. Sick Co-Founder @ Cascade Prodrug
Co-Founder

allan-cochrane_image

Allan Cochrane
Allan Cochrane Co-Founder @ Cascade Prodrug
Co-Founder

john-nepute_image

John Nepute
John Nepute CFO @ Cascade Prodrug
CFO

Founder


allan-cochrane_image

Allan Cochrane

august-j-sick_image

August J. Sick

Investors List

elevate-capital_image

Elevate Capital

Elevate Capital investment in Series B - Cascade Prodrug

Official Site Inspections

http://www.cascadeprodrug.com

  • Host name: 95.70.73.34.bc.googleusercontent.com
  • IP address: 34.73.70.95
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Cascade Prodrug"

ABOUT US - Cascade Prodrug, Inc.

Cascade Prodrug is dedicated to furthering the development of its lead candidate, CPD100Li, developed from their hypoxia-activated switch technology to improve the therapeutic options โ€ฆSee details»

TEAM - Cascade Prodrug, Inc.

Mr. Nepute comes to Cascade Prodrug with significant experience in financial and business development roles. Most notably, Mr. Nepute was the President of Monaco Coach Corporation where he led investor relations, M&A, operations, โ€ฆSee details»

Cascade Prodrug - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number (541)343-6025 Cascade Prodrug they give service for prostate, cervical, pancreatic, non-small cell lung cancer, and head and neck โ€ฆSee details»

Cascade Prodrug, Inc. - Drug pipelines, Patents, Clinical trials

Explore Cascade Prodrug, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease ...See details»

Cascade Prodrug Inc. | LinkedIn

Cascade Prodrug Inc. | 60 followers on LinkedIn. Cascade Prodrug is developing novel prodrugs targeting hypoxia for the treatment of cancer patients. | Cascade Prodrug, Incorporated is a โ€ฆSee details»

Cascade Prodrug - VentureRadar

Cascade Prodrug is developing drug therapies for the treatment of hyper-proliferative diseases using technologies including prodrug derivatives of... ... Find out ...See details»

Cascade Prodrug Inc | Eugene, OR, USA Startup

Website cascadeprodrug.com; Company Summary Cascade Prodrug Inc is in preclinical development of a novel drug utilizing it's proprietary technology platform. This compound is a prodrug derivative of blockbuster FDA approved โ€ฆSee details»

Cascade Announces Poster Presentation at Society for โ€ฆ

EUGENE, Ore., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cascade Prodrug Inc. (Cascade), a private preclinical-stage biotechnology company focused on developing novel small molecule โ€ฆSee details»

Cascade Prodrug - PitchBook

Cascade Prodrug General Information Description. Developer of chemotherapy technology designed to treat a variety of solid tumor indications. The company's technology specializes in โ€ฆSee details»

PARTNERING โ€“ Cascade Prodrug, Inc.

A New Approach Cascade Prodrug is pursuing a strategy focused on bringing a novel hypoxia-activated therapy into clinical development for treating solid tumors. Cascadeโ€™s initial preclinical lead candidate is CPD100Li. We are currently โ€ฆSee details»

Orphanet: Cascade Prodrug, Inc

Knowledge on rare diseases and orphan drugs COVID-19 & Rare diseases Rare Diseases Resources for Refugees/Displaced PersonsSee details»

Cascade Prodrug - Craft

Cascade Prodrug is a company dedicated to the development of its proprietary hypoxia-activated switch technology. Its lead compound, CPD100, is a proprietary N-oxide prodrug of โ€ฆSee details»

Cascade Prodrug - Products, Competitors, Financials, Employees ...

Cascade Announces Poster Presentation at Society for Immunotherapy of Cancer (SITC) Annual Meeting. Oct 24, 2023. Location: Exhibit Hall Exhibit Halls A and B1 โ€“ San Diego Convention โ€ฆSee details»

CONTACT - Cascade Prodrug, Inc.

Interested in learning more about partnering opportunities? Send us an email at: [email protected] QUICK LINKS About Us Meet Our Team Pipeline โ€ฆSee details»

Cascade Announces Poster Presentation at Society for

EUGENE, Ore., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cascade Prodrug Inc. (Cascade), a private preclinical-stage biotechnology company focused on developing novel small molecule โ€ฆSee details»

Cascade Prodrug - Elevate Capital

Cascade Prodrug has developed a proprietary anticancer strategy that will significantly improve the chemotherapy options for solid tumors. Cascade is able to address the toxicity associated โ€ฆSee details»

NEWS โ€“ Cascade Prodrug, Inc.

October 2023 Cascade Announces Poster Presentation at Society for Immunotherapy of Cancer (SITC) Annual Meeting EUGENE, Ore., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cascade โ€ฆSee details»

Organizations Unite to Increase the Appropriate Use of โ€ฆ

Dec 2, 2024 Canadaโ€™s Drug Agency is a pan-Canadian health organization. Created and funded by Canadaโ€™s federal, provincial, and territorial governments, weโ€™re responsible for driving โ€ฆSee details»

PUBLICATIONS โ€“ Cascade Prodrug, Inc.

September 20, 2023 CPD 100Li โ€“ Targeting the Tumor Microenvironment David Regan, MD โ€“ Director of Medical Affairs Thomas K. Wuest, MD, MMM โ€“ BOD Advisor Abstract CPD 100LiSee details»

linkstock.net © 2022. All rights reserved